Valganciclovir
12 FDA-DMF suppliersSmall Molecule
Overview
Valganciclovir is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201314).
API suppliers (7)
Suppliers of Valganciclovir backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- OLON SPAItaly4 active DMF
- APITORIA PHARMA PRIVATE LTDIndia2 active DMF
- MATRIX PHARMACORP PRIVATE LTD2 active DMF
- Dr. Reddy's Laboratories Ltd.India2 active DMF
- APOTEX PHARMACHEM INC
- Sun Pharmaceutical Industries LimitedIndia
- Zhejiang Hisun Pharmaceutical Co., Ltd.China
Patent & exclusivity (US)
Per the FDA Orange Book (18 approved US products), the latest listed US patent on Valganciclovir expires 11 Dec 2027. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- [2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-2-amino-3-methylbutanoate
- Canonical SMILES
- CC(C)[C@@H](C(=O)OCC(CO)OCN1C=NC2=C1NC(=NC2=O)N)N
- InChIKey
- WPVFJKSGQUFQAP-GKAPJAKFSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.